Cargando…

GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION

We studied the influence of glucocorticoids on the sensitization phase as well as on the cytolytic effector phase of an in vitro lymphocyte-mediated immune reaction. Lymphocytes obtained from the spleens or lymph nodes of unimmunized inbred rats were sensitized against foreign rat or mouse embryonic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Irun R., Stavy, Lary, Feldman, Michael
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1970
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2180508/
https://www.ncbi.nlm.nih.gov/pubmed/5511566
_version_ 1782145562727940096
author Cohen, Irun R.
Stavy, Lary
Feldman, Michael
author_facet Cohen, Irun R.
Stavy, Lary
Feldman, Michael
author_sort Cohen, Irun R.
collection PubMed
description We studied the influence of glucocorticoids on the sensitization phase as well as on the cytolytic effector phase of an in vitro lymphocyte-mediated immune reaction. Lymphocytes obtained from the spleens or lymph nodes of unimmunized inbred rats were sensitized against foreign rat or mouse embryonic fibroblasts in cell culture. The capacity of the sensitized lymphocytes to produce a cytolytic effect was tested by transferring them to target fibroblast cultures. Injury to target fibroblasts was measured by release of radioactive (51)Cr from previously labeled fibroblasts or by direct count of viable fibroblasts after incubation with sensitized lymphocytes. Various concentrations of water-soluble hydrocortisone or prednisolone were added to cell cultures during the 5 day sensitization phase and/or during the subsequent cytolytic effector phase and the influence of these hormones on the number and cytolytic capacity of the lymphocytes was measured. During the sensitization phase, the presence of glucocorticoid hormones, at concentrations of about 1 µg/ml, led to a profound decrease in the total number of recoverable lymphocytes. However, the per cent of large transformed lymphocytes was much greater in these treated cultures. The antigen-specific cytolytic capacity per cell of the glucocorticoid-treated lymphocytes, after the hormone was removed, was several times greater than that of lymphocytes sensitized in the absence of added hormones. Glucocorticoids influenced the effector phase of the reaction by inhibiting lymphocyte-mediated injury to target fibroblasts. The hormones, at concentrations of about 1 µg/ml, inhibited the cytolytic effect by about 50% without reducing the viability of the sensitized lymphocytes. Dose-dependent toxicity to lymphocytes and increasing inhibition of cytolytic effect appeared at higher concentrations of hormones. Thus, hydrocortisone and prednisolone, at concentrations of about 1 µg/ml, did not suppress the induction of sensitization, a process which they seem to facilitate in vitro. However, similar concentrations of these hormones appear to inhibit the cytolytic effector mechanism of sensitized lymphocytes. These findings may be relevant to the use of glucocorticoids as immunosuppressive agents in vivo.
format Text
id pubmed-2180508
institution National Center for Biotechnology Information
language English
publishDate 1970
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21805082008-04-17 GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION Cohen, Irun R. Stavy, Lary Feldman, Michael J Exp Med Article We studied the influence of glucocorticoids on the sensitization phase as well as on the cytolytic effector phase of an in vitro lymphocyte-mediated immune reaction. Lymphocytes obtained from the spleens or lymph nodes of unimmunized inbred rats were sensitized against foreign rat or mouse embryonic fibroblasts in cell culture. The capacity of the sensitized lymphocytes to produce a cytolytic effect was tested by transferring them to target fibroblast cultures. Injury to target fibroblasts was measured by release of radioactive (51)Cr from previously labeled fibroblasts or by direct count of viable fibroblasts after incubation with sensitized lymphocytes. Various concentrations of water-soluble hydrocortisone or prednisolone were added to cell cultures during the 5 day sensitization phase and/or during the subsequent cytolytic effector phase and the influence of these hormones on the number and cytolytic capacity of the lymphocytes was measured. During the sensitization phase, the presence of glucocorticoid hormones, at concentrations of about 1 µg/ml, led to a profound decrease in the total number of recoverable lymphocytes. However, the per cent of large transformed lymphocytes was much greater in these treated cultures. The antigen-specific cytolytic capacity per cell of the glucocorticoid-treated lymphocytes, after the hormone was removed, was several times greater than that of lymphocytes sensitized in the absence of added hormones. Glucocorticoids influenced the effector phase of the reaction by inhibiting lymphocyte-mediated injury to target fibroblasts. The hormones, at concentrations of about 1 µg/ml, inhibited the cytolytic effect by about 50% without reducing the viability of the sensitized lymphocytes. Dose-dependent toxicity to lymphocytes and increasing inhibition of cytolytic effect appeared at higher concentrations of hormones. Thus, hydrocortisone and prednisolone, at concentrations of about 1 µg/ml, did not suppress the induction of sensitization, a process which they seem to facilitate in vitro. However, similar concentrations of these hormones appear to inhibit the cytolytic effector mechanism of sensitized lymphocytes. These findings may be relevant to the use of glucocorticoids as immunosuppressive agents in vivo. The Rockefeller University Press 1970-11-30 /pmc/articles/PMC2180508/ /pubmed/5511566 Text en Copyright © 1970 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Cohen, Irun R.
Stavy, Lary
Feldman, Michael
GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION
title GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION
title_full GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION
title_fullStr GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION
title_full_unstemmed GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION
title_short GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO : FACILITATION OF THE SENSITIZATION PHASE AND INHIBITION OF THE EFFECTOR PHASE OF A LYMPHOCYTE ANTI-FIBROBLAST REACTION
title_sort glucocorticoids and cellular immunity in vitro : facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2180508/
https://www.ncbi.nlm.nih.gov/pubmed/5511566
work_keys_str_mv AT cohenirunr glucocorticoidsandcellularimmunityinvitrofacilitationofthesensitizationphaseandinhibitionoftheeffectorphaseofalymphocyteantifibroblastreaction
AT stavylary glucocorticoidsandcellularimmunityinvitrofacilitationofthesensitizationphaseandinhibitionoftheeffectorphaseofalymphocyteantifibroblastreaction
AT feldmanmichael glucocorticoidsandcellularimmunityinvitrofacilitationofthesensitizationphaseandinhibitionoftheeffectorphaseofalymphocyteantifibroblastreaction